KLARSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.19 EUR | -3.52% |
|
-22.48% | -19.49% |
| 03-15 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
| 2023 | Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 2.500 | 3.380 | 2.900 |
| Spread/Res. | -12.40% | -35.21% | -24.48% |
| Spread/Supp. | +5.80% | +5.80% | +9.50% |
| Support | 2.070 | 2.070 | 2.000 |
- Stock Market
- Equities
- ALKLA Stock
- Charts Klarsen
